FEVERTREE DRINKS PLC ORD GBP0.0025

Symbol: FEVR

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date 15 May 2025
Pay Date 20 Jun 2025
Total Dividends - Year to Date16.97
Dividend Yield (%)2.201

Historical Data & Ratios

Avg Volume Over 10 Days0.6530
Market Cap (M)961.7672
Price/Earnings (PE)36.89
Earnings Per Share20.9
Revenue Per Share3.1492
Return on Equity %10.0722

1 Month Performance Chart

One Month Chart

Broker View
Data shown is based on the past 75 days of broker views.

ActionBrokers

Strong Buy2

Buy3

Neutral11

Sell3

Strong Sell0

Brokers 2 3 11 3 0
Consensus

ConsensusNeutral

Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here
0.30%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      Fevertree Drinks PLC is a United Kingdom-based supplier of carbonated mixers. The Company’s products include Premium Indian Tonic, Flavored Tonics, Ginger Ales, Ginger Beers and Colas, Lemonades, Sodas, Adult Soft Drinks and Cocktail Mixers. Its mixers include Margarita Mixer, Espresso Martini, Mojito Mixer, Premium Indian Tonic Water, Elderflower Tonic Water, Mediterranean Tonic Water, Premium Soda Water, Raspberry and Orange Blossom Soda, Mexican Lime Soda, Ginger Beer, Ginger ALE, Spiced Orange Ginger ALE, Sicilian Lemonade, and others. It sells its products to a range of markets, such as the United Kingdom, the United States, Europe, and the rest of the world. The Company's subsidiaries include Fevertree Limited, Fevertree USA Inc., Fevertree USA Holding Co. Inc., Fevertree USA Production Co. Inc., Fevertree US Limited, Fevertree ROW Limited, GDP Global Drinks Partnership GmbH, Powell & Mahoney Ltd, Fevertree Germany Limited, among others.

      Financial Summary

      BRIEF: For the six months ended 30 June 2024, Fevertree Drinks PLC revenues decreased 2% to £172.9M. Net income increased from £1.1M to £7.6M. Revenues reflect Europe segment decrease of 17% to £46.8M, United Kingdom segment decrease of 5% to £50.9M. Net income reflects Alcoholic Sprits suppliers segment income increase from £600K to £12.2M. Dividend per share remained flat at £0.06.

      Financials


      Income Statement - All values are in GBP (M).

      Year Ending

      31/12/2018

      31/12/2017

      31/12/2016

      31/12/2015

      31/12/2014

      30/06/2014

      Total Revenue 237.45 170.17 102.24 59.25 34.69 16.25
      Gross profit 122.96 91.10 56.42 30.87 17.66 7.53
      Operating Profit/Loss 75.36 56.40 34.37 17.27 8.09 3.62
      Profit Before Tax 75.58 56.43 34.30 16.76 2.52 3.62
      Profit After Tax 61.78 45.51 27.50 13.33 1.30 2.65
      Equity Holders of Parent Company 61.78 45.51 27.50 13.33 1.30 2.65
      Minority Interest NIL NIL NIL NIL NIL NIL


      Balance Sheet - All values are in GBP (M).

      Year Ending

      31/12/2018

      31/12/2017

      31/12/2016

      31/12/2015

      31/12/2014

      30/06/2014

      Total Non-Current Assets 44.43 45.78 44.29 44.44 44.92 0.02
      Total Current Assets 180.96 126.01 73.88 40.81 22.33 9.95
      Total Assets 225.38 171.79 118.17 85.25 67.25 9.97
      Total Liabilities 42.22 41.71 29.18 19.83 13.99 NIL
      Total Net Assets 183.17 130.08 88.99 65.42 53.27 NIL
      Shareholders Funds 183.17 130.08 88.99 65.42 53.27 7.61
      Minority Interests NIL NIL NIL NIL NIL NIL
      Total Equity 183.17 130.08 88.99 65.42 53.27 NIL

      Outlook

      Broker View
      Data shown is based on the past 75 days of broker views.

      ActionBrokers

      Strong Buy2

      Buy3

      Neutral11

      Sell3

      Strong Sell0

      Brokers 2 3 11 3 0
      Consensus

      ConsensusNeutral

      Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

      © 2022 Refinitiv, an LSEG business. All rights reserved.

      Forecasts

      Year 2025 2026 2027
      Revenue £376.44mn £414.61mn £454.13mn
      Pre-tax-Profit £33.76mn £39.99mn £52.62mn
      EPS £0.24p £0.28p £0.38p
      EPS Growth -15.10% 19.49% 31.99%
      P/E 32.95 27.62 20.97
      PEG Ratio -2.18 1.42 0.66
      Dividend 16.87p 18.29p 20.90p
      Yield 0.00% 0.00% 0.00%

      Upgrades & Downgrades (Latest)

      DateBrokerRecommendationPriceOld TargetNew TargetChange
      13th Sep 2024DeutscheReiteration766p1450p1325pBuy
      29th Jul 2024JefferiesReiteration927p1150p1000pHold
      18th Jul 2024JP Morgan CazenoveReiteration991p2720p2650pNeutral
      30th Apr 2024DeutscheNew Coverage1133p0p1600pBuy
      11th Apr 2024RBC Capital MarketsReiteration1097p0p1200pSector perform
      6th Nov 2023BarclaysReiteration1088p1310p1380pEqual-weight
      25th May 2023RBC Capital MarketsReiteration1423p1000p1500pHold
      25th May 2023NumisReiteration1423p0p1500pBuy

      Time & Sales

      All prices are in GBX and times are in GMT. Last 20 trades shown. Trade type is estimated and should be treated as indicative only.

      Date Time Price Volume Type
      25 Apr 2025 16:35 766 1,057 Buy
      25 Apr 2025 16:35 766 988 Buy
      25 Apr 2025 16:35 766 673 Buy
      25 Apr 2025 16:35 766 640 Buy
      25 Apr 2025 16:35 766 52 Buy
      25 Apr 2025 16:35 766 34 Buy
      25 Apr 2025 16:35 766 12 Buy
      25 Apr 2025 16:35 766 51,528 Buy
      25 Apr 2025 16:29 765 1 Buy
      25 Apr 2025 16:29 764 8 Sell
      25 Apr 2025 16:28 765 258 Sell
      25 Apr 2025 16:28 765 93 Sell
      25 Apr 2025 16:28 765 10 Sell
      25 Apr 2025 16:27 767 1 Buy
      25 Apr 2025 16:27 766 71 Sell
      25 Apr 2025 16:27 766 19 Sell
      25 Apr 2025 16:27 766 1 Sell
      25 Apr 2025 16:27 766 180 Sell
      25 Apr 2025 16:27 766 85 Sell
      25 Apr 2025 16:27 766 240 Sell

      Selected data supplied by Thomson Reuters ©  View restrictions.

      Investment involves risk. You may get back less than invested.